| scholarly article | Q13442814 |
| P2093 | author name string | Choi JH | |
| Jang CH | |||
| Jue DM | |||
| Byun MS | |||
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis | Q28239197 | ||
| A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF | Q28296638 | ||
| The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses | Q29542806 | ||
| Role of cytokines in rheumatoid arthritis | Q29620713 | ||
| Negative regulatory role of overexpression of PLC gamma 1 in the expression of early growth response 1 gene in rat 3Y1 fibroblasts | Q30165153 | ||
| Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy | Q33557174 | ||
| Cytokine pathways and joint inflammation in rheumatoid arthritis | Q33939087 | ||
| Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts | Q36209351 | ||
| The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles | Q36863973 | ||
| Anti-malarials in dermatology | Q40244962 | ||
| Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis | Q40587405 | ||
| Inhibition of mitogen-activated protein kinase signaling by chloroquine | Q40733870 | ||
| Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase | Q40878541 | ||
| Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis | Q41702676 | ||
| Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages | Q41721832 | ||
| Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis | Q41913749 | ||
| Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells | Q41917909 | ||
| Pharmacologic actions of 4-aminoquinoline compounds | Q41921024 | ||
| Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism | Q41921412 | ||
| Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo | Q42807214 | ||
| Defining protective responses to pathogens: cytokine profiles in leprosy lesions | Q43702135 | ||
| Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. | Q46825011 | ||
| Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. | Q50850177 | ||
| In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis | Q59276547 | ||
| P433 | issue | 6 | |
| P921 | main subject | lipopolysaccharide | Q421804 |
| chloroquine | Q422438 | ||
| P304 | page(s) | 703-710 | |
| P577 | publication date | 2006-01-17 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes | |
| P478 | volume | 45 |
| Q36491320 | A human liver microphysiology platform for investigating physiology, drug safety, and disease models |
| Q28475036 | A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults |
| Q36656237 | Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus. |
| Q34184151 | Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort |
| Q46874492 | Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment |
| Q47144740 | Are respiratory complications of Plasmodium vivax malaria an underestimated problem? |
| Q47628090 | Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis |
| Q97883544 | Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine |
| Q92403288 | Bitter Taste Receptors for Asthma Therapeutics |
| Q89848603 | CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine |
| Q37403811 | Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment |
| Q35079032 | Characterization of macroautophagic flux in vivo using a leupeptin-based assay |
| Q94561886 | Chloroquine and hydroxychloroquine in the context of COVID-19 |
| Q97643153 | Chloroquine as a promising adjuvant therapy for type 1 Diabetes Mellitus |
| Q38992369 | Chloroquine attenuates lipopolysaccharide-induced inflammatory responses through upregulation of USP25. |
| Q41920583 | Chloroquine differentially modulates inflammatory cytokine expression in RAW 264.7 cells in response to inactivated Staphylococcus aureus. |
| Q33617999 | Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model |
| Q39887289 | Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis |
| Q40208955 | Chloroquine interferes with dengue-2 virus replication in U937 cells |
| Q90999599 | Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases |
| Q39225515 | Chloroquine relieves acute lung injury in rats with acute hemorrhagic necrotizing pancreatitis |
| Q41636898 | Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis. |
| Q39644479 | Combined effects of proinflammatory cytokines and intermittent cyclic mechanical strain in inhibiting osteogenicity in human periodontal ligament cells |
| Q50916795 | Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q34636680 | Current and emerging strategies for the management of sarcoidosis |
| Q33532741 | Development of novel adenosine monophosphate-activated protein kinase activators |
| Q38645738 | Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics. |
| Q39155625 | Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo |
| Q35925680 | Effect of chloroquine on gene expression of Plasmodium yoelii nigeriensis during its sporogonic development in the mosquito vector |
| Q36751710 | Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis |
| Q38729021 | Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis |
| Q54332206 | Escherichia coli flagellin stimulates pro-inflammatory immune response. |
| Q92323477 | Evaluation of anti-inflammatory effect of Varanadi Kashayam (decoction) in THP-1-derived macrophages |
| Q92026856 | Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues |
| Q35239986 | Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages |
| Q39321571 | GADD45γ regulates TNF-α and IL-6 synthesis in THP-1 cells |
| Q35147809 | Genome-wide transcriptional profiling of skin and dorsal root ganglia after ultraviolet-B-induced inflammation |
| Q56378691 | Hemozoin-induced activation of human monocytes toward M2-like phenotype is partially reversed by antimalarial drugs-chloroquine and artemisinin |
| Q37627791 | Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation |
| Q47095505 | Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury |
| Q104617060 | Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons |
| Q96110894 | Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? |
| Q53609113 | Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. |
| Q30540705 | Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. |
| Q28548561 | Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease |
| Q35891642 | Induction of autophagy is essential for monocyte-macrophage differentiation |
| Q64935868 | Inhibition of neddylation plays protective role in lipopolysaccharide-induced kidney damage through CRL-mediated NF-κB pathways. |
| Q39289744 | Inhibition of neddylation represses lipopolysaccharide-induced proinflammatory cytokine production in macrophage cells. |
| Q36868230 | Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts. |
| Q38870485 | Investigational drugs in early development for treating dengue infection. |
| Q98775698 | Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants |
| Q41849684 | Macrophages and angiogenesis in rheumatic diseases |
| Q64885608 | Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological System. |
| Q53126529 | Molecular Responses of Human Retinal Cells to Infection with Dengue Virus. |
| Q98946012 | Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19 |
| Q38026787 | New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. |
| Q90327245 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| Q59791387 | Novel Liposome Eencapsulated Guanosine Di Phosphate based Therapeutic Target against Anemia of Inflammation |
| Q99579307 | Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations |
| Q34989470 | PIKfyve regulates the endosomal localization of CpG oligodeoxynucleotides to elicit TLR9-dependent cellular responses |
| Q99616870 | Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives |
| Q41911824 | Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer |
| Q54938157 | Phytochemicals as modulators of M1-M2 macrophages in inflammation. |
| Q38932478 | Piperine Suppresses the Expression of CXCL8 in Lipopolysaccharide-Activated SW480 and HT-29 Cells via Downregulating the Mitogen-Activated Protein Kinase Pathways. |
| Q39245418 | Plasmodium vivax trophozoites insensitive to chloroquine |
| Q95843513 | Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy? |
| Q35202866 | Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis |
| Q54300097 | Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations. |
| Q54243362 | Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man. |
| Q91912027 | Simvastatin attenuates the lipopolysaccharideinduced inflammatory response of rat pulmonary microvascular endothelial cells by downregulating toll-like receptor 4 expression |
| Q55052043 | Spiranthes sinensis Suppresses Production of Pro-Inflammatory Mediators by Down-Regulating the NF-κB Signaling Pathway and Up-Regulating HO-1/Nrf2 Anti-Oxidant Protein. |
| Q44954268 | Stenotrophomonas maltophilia fimbrin stimulates mouse bladder innate immune response |
| Q64085327 | TLR4/NF-κB axis signaling pathway-dependent up-regulation of miR-625-5p contributes to human intervertebral disc degeneration by targeting |
| Q47104338 | Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors. |
| Q41928709 | The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis. |
| Q37184778 | The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats |
| Q94672281 | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? |
| Q37947108 | The role of antimalarial agents in the treatment of SLE and lupus nephritis |
| Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
| Q53674487 | Toll-like receptor 4 is involved in bacterial endotoxin-induced endothelial cell injury and SOC-mediated calcium regulation. |
| Q53614685 | Toll-like receptors: a new target in rheumatoid arthritis? |
| Q39095616 | Total synthesis of a glycoglycerolipid from Meiothermus taiwanensis through a one-pot glycosylation reaction and exploration of its immunological properties |
| Q38335622 | Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine. |
| Q107473206 | What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology |
| Q98562940 | microRNA-495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF-κB pathway by targeting RALB |
Search more.